What is the Glaxosmithkline Pharmaceuticals Ltd share price today?

The share price of NSE:GLAXO-EQ on 01 Oct 2026 (as of 15:03:36 IST) is ₹2780.3.

What is the NSE:GLAXO-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:GLAXO-EQ 52 week high low range shows a high of ₹3120.7 and a low of ₹2088.1.

What is the Glaxosmithkline Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Glaxosmithkline Pharmaceuticals Ltd market cap is ₹468848000000.

What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd Stock?

The shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 75% Foreign Institutional Investors (FII): 4.79% Domestic Institutional Investors (DII): 2.94% Mutual Funds: 4.87% Retail & Others: 12.4% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Glaxosmithkline Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Glaxosmithkline Pharmaceuticals Ltd is 43.8935, and the Price-to-Book (PB) ratio is 16.9426, as on 01 Oct 2026.

Glaxosmithkline Pharmaceuticals Share Price

2575.10+43.70 (+1.73%)

-4.01% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+1.73%

1 Week

+3.24%

1 Month

-5.77%

3 Month

-0.17%

6 Month

+3.96%

YTD

+4.10%

1 Year

-4.01%

5 Year

+56.95%

10 Year

+82.74%

Max

+1511.96%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

2540.40

2494.30

2344.10

2088.10

High

2605.90

2762.90

3120.70

About

GlaxoSmithKline (GSK) Pharmaceuticals, a subsidiary of UK-based GSK plc, is a leading global biopharma company bringing together science, technology and talent to deliver impact and get ahead of disease together Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

GLAXONSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

2575+59.9 (2.38%)

2479.30

2605.90

42,832Cr

Glaxosmithkline Pharmaceuticals Share Price

2575.10+43.70 (+1.73%)

-4.01% past 1 Year

Financial overview

Compounded Sales Growth

10 years3%

5 years5%

3 years6%

Last year2%

Compounded Profit Growth

10 years11%

5 years24%

3 years19%

Last year12%

Stock Price CAGR

10 years6%

5 years9%

3 years22%

1 year-4%

Return on Equity

10 years25%

5 years36%

3 years44%

Last year49%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
3%	5%	6%	2%
11%	24%	19%	12%
6%	9%	22%	-4%
25%	36%	44%	49%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

GLAXO

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
2,575	₹42832 Cr	40.1	14	66.99	₹1036 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018
₹1184 Cr	₹938 Cr	₹995 Cr	₹1041 Cr	₹980 Cr	₹805 Cr	₹974 Cr	₹949 Cr	₹1011 Cr	₹815 Cr	₹930 Cr	₹805 Cr	₹957 Cr	₹762 Cr	₹787 Cr	₹802 Cr	₹917 Cr	₹745 Cr	₹810 Cr	₹816 Cr	₹1010 Cr	₹718 Cr	₹744 Cr	₹792 Cr	₹879 Cr	₹649 Cr	₹776 Cr	₹779 Cr	₹882 Cr	₹788 Cr	₹751 Cr	₹825 Cr	₹816 Cr	₹736 Cr
₹73 Cr	₹44 Cr	₹36 Cr	₹32 Cr	₹34 Cr	₹44 Cr	₹41 Cr	₹35 Cr	₹35 Cr	₹36 Cr	₹30 Cr	₹28 Cr	₹28 Cr	₹36 Cr	₹28 Cr	₹23 Cr	₹22 Cr	₹28 Cr	₹19 Cr	₹10 Cr	₹15 Cr	₹32 Cr	₹30 Cr	₹14 Cr	₹9 Cr	₹58 Cr	₹16 Cr	₹17 Cr	₹16 Cr	₹31 Cr	₹53 Cr	₹17 Cr	₹15 Cr	₹18 Cr
₹1256 Cr	₹982 Cr	₹1031 Cr	₹1073 Cr	₹1014 Cr	₹849 Cr	₹1015 Cr	₹984 Cr	₹1045 Cr	₹850 Cr	₹960 Cr	₹833 Cr	₹985 Cr	₹798 Cr	₹815 Cr	₹826 Cr	₹939 Cr	₹773 Cr	₹828 Cr	₹826 Cr	₹1025 Cr	₹750 Cr	₹774 Cr	₹806 Cr	₹888 Cr	₹707 Cr	₹792 Cr	₹795 Cr	₹898 Cr	₹819 Cr	₹804 Cr	₹842 Cr	₹831 Cr	₹754 Cr
₹797 Cr	₹659 Cr	₹658 Cr	₹690 Cr	₹662 Cr	₹569 Cr	₹656 Cr	₹676 Cr	₹706 Cr	₹601 Cr	₹691 Cr	₹604 Cr	₹686 Cr	₹634 Cr	₹635 Cr	₹590 Cr	₹676 Cr	₹612 Cr	₹650 Cr	₹636 Cr	₹751 Cr	₹603 Cr	₹605 Cr	₹629 Cr	₹696 Cr	₹556 Cr	₹625 Cr	₹673 Cr	₹711 Cr	₹642 Cr	₹602 Cr	₹700 Cr	₹663 Cr	₹611 Cr
₹475 Cr	₹339 Cr	₹387 Cr	₹403 Cr	₹369 Cr	₹295 Cr	₹374 Cr	₹327 Cr	₹356 Cr	₹266 Cr	₹287 Cr	₹246 Cr	₹318 Cr	₹180 Cr	₹197 Cr	₹252 Cr	₹279 Cr	₹177 Cr	₹194 Cr	₹208 Cr	₹291 Cr	₹164 Cr	₹186 Cr	₹195 Cr	₹214 Cr	₹172 Cr	₹189 Cr	₹141 Cr	₹210 Cr	₹196 Cr	₹216 Cr	₹154 Cr	₹180 Cr	₹154 Cr
₹49 L	₹97 L	₹61 L	₹1 Cr	₹51 L	₹42 L	₹58 L	₹9 L	₹27 L	₹37 L	₹77 L	₹32 L	₹43 L	₹28 L	₹65 L	₹9 L	₹39 L	₹68 L	₹28 L	₹58 L	₹35 L	₹79 L	₹63 L	₹94 L	₹88 L	₹1 Cr	₹2 Cr	₹3 Cr	₹92 L	₹93 L	₹8 L	₹5 L	₹22 L	₹20 L
₹459 Cr	₹322 Cr	₹373 Cr	₹400 Cr	₹354 Cr	₹279 Cr	₹359 Cr	₹308 Cr	₹344 Cr	₹249 Cr	₹271 Cr	₹65 Cr	₹299 Cr	₹181 Cr	₹190 Cr	₹224 Cr	₹262 Cr	₹160 Cr	₹208 Cr	₹172 Cr	₹274 Cr	₹146 Cr	₹49 Cr	₹187 Cr	₹127 Cr	₹149 Cr	₹177 Cr	-₹634 Cr	₹587 Cr	₹176 Cr	₹222 Cr	₹170 Cr	₹157 Cr	₹134 Cr
₹336 Cr	₹237 Cr	₹278 Cr	₹296 Cr	₹257 Cr	₹205 Cr	₹263 Cr	₹230 Cr	₹253 Cr	₹182 Cr	₹194 Cr	₹46 Cr	₹218 Cr	₹132 Cr	₹133 Cr	₹165 Cr	₹193 Cr	₹119 Cr	₹1219 Cr	₹150 Cr	₹204 Cr	₹121 Cr	₹14 Cr	₹157 Cr	₹76 Cr	₹111 Cr	₹138 Cr	-₹661 Cr	₹503 Cr	₹114 Cr	₹147 Cr	₹114 Cr	₹101 Cr	₹84 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006	Dec 2005	Dec 2004	Dec 2003	Dec 2002
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹169 Cr	₹169 Cr	₹169 Cr	₹169 Cr	₹169 Cr	₹169 Cr	₹169 Cr	₹169 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹87 Cr	₹74 Cr	₹74 Cr
-₹16 Cr	-₹15 Cr	-₹9 Cr	-₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹2114 Cr	₹1797 Cr	₹1617 Cr	₹1574 Cr	₹2494 Cr	₹1309 Cr	₹1651 Cr	₹1970 Cr	₹1973 Cr	₹1922 Cr	₹2099 Cr	₹1744 Cr	₹1905 Cr	₹1922 Cr	₹1851 Cr	₹1867 Cr	₹1701 Cr	₹1491 Cr	₹1296 Cr	₹1120 Cr	₹868 Cr	₹836 Cr	₹588 Cr	₹497 Cr
₹2114 Cr	₹1797 Cr	₹1617 Cr	₹1574 Cr	₹2494 Cr	₹1309 Cr	₹1651 Cr	₹1970 Cr	₹1973 Cr	₹1922 Cr	₹2099 Cr	₹1744 Cr	₹1905 Cr	₹1922 Cr	₹1851 Cr	₹1867 Cr	₹1701 Cr	₹1491 Cr	₹1296 Cr	₹1120 Cr	₹868 Cr	₹836 Cr	₹588 Cr	₹497 Cr
₹2267 Cr	₹1951 Cr	₹1778 Cr	₹1741 Cr	₹2663 Cr	₹1478 Cr	₹1821 Cr	₹2140 Cr	₹2057 Cr	₹2007 Cr	₹2183 Cr	₹1829 Cr	₹1990 Cr	₹2007 Cr	₹1936 Cr	₹1952 Cr	₹1786 Cr	₹1576 Cr	₹1381 Cr	₹1205 Cr	₹953 Cr	₹924 Cr	₹662 Cr	₹571 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 L	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹2 L	₹18 L	₹58 L	₹99 L	₹2 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr
-₹134 Cr	-₹141 Cr	-₹146 Cr	-₹134 Cr	-₹113 Cr	-₹103 Cr	-₹110 Cr	-₹62 Cr	-₹104 Cr	-₹92 Cr	-₹101 Cr	-₹83 Cr	-₹92 Cr	-₹87 Cr	-₹62 Cr	-₹57 Cr	-₹45 Cr	-₹30 Cr	-₹20 Cr	-₹25 Cr	-₹30 Cr	-₹45 Cr	-₹30 Cr	-₹33 Cr
₹17 Cr	₹2 Cr	₹7 Cr	₹4 Cr	₹10 Cr	₹22 Cr	₹29 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹260 Cr	₹249 Cr	₹247 Cr	₹255 Cr	₹262 Cr	₹259 Cr	₹262 Cr	₹2920 Cr	₹2733 Cr	₹3787 Cr	₹3592 Cr	₹272 Cr	₹242 Cr	₹236 Cr	₹225 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹144 Cr	₹111 Cr	₹108 Cr	₹125 Cr	₹159 Cr	₹179 Cr	₹180 Cr	₹2860 Cr	₹2632 Cr	₹3700 Cr	₹3498 Cr	₹197 Cr	₹159 Cr	₹158 Cr	₹173 Cr	-₹51 Cr	-₹39 Cr	-₹24 Cr	-₹15 Cr	-₹19 Cr	-₹25 Cr	-₹41 Cr	-₹27 Cr	-₹31 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹570 Cr	₹708 Cr	₹625 Cr	₹428 Cr	₹579 Cr	₹466 Cr	₹357 Cr	₹406 Cr	₹506 Cr	₹279 Cr	₹328 Cr	₹308 Cr	₹286 Cr	₹237 Cr	₹201 Cr	₹334 Cr	₹294 Cr	₹255 Cr	₹228 Cr	₹233 Cr	₹240 Cr	₹206 Cr	₹193 Cr	₹185 Cr
₹244 Cr	₹256 Cr	₹207 Cr	₹185 Cr	₹504 Cr	₹450 Cr	₹223 Cr	₹803 Cr	₹842 Cr	₹390 Cr	₹203 Cr	₹130 Cr	₹84 Cr	₹87 Cr	₹67 Cr	₹13 Cr	₹23 Cr	₹21 Cr	₹19 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹15 Cr	₹15 Cr
₹965 Cr	₹941 Cr	₹692 Cr	₹714 Cr	₹615 Cr	₹438 Cr	₹442 Cr	₹1596 Cr	₹1601 Cr	₹212 Cr	₹253 Cr	₹668 Cr	₹519 Cr	₹512 Cr	₹592 Cr	₹498 Cr	₹381 Cr	₹2234 Cr	₹393 Cr	₹318 Cr	₹291 Cr	₹1187 Cr	₹770 Cr	₹652 Cr
₹1779 Cr	₹1905 Cr	₹1525 Cr	₹1326 Cr	₹1698 Cr	₹1355 Cr	₹1022 Cr	₹2804 Cr	₹2949 Cr	₹881 Cr	₹784 Cr	₹1107 Cr	₹889 Cr	₹836 Cr	₹860 Cr	₹845 Cr	₹699 Cr	₹2510 Cr	₹640 Cr	₹568 Cr	₹546 Cr	₹1408 Cr	₹978 Cr	₹851 Cr
₹4190 Cr	₹3967 Cr	₹3410 Cr	₹3193 Cr	₹4520 Cr	₹3012 Cr	₹3023 Cr	₹7804 Cr	₹7639 Cr	₹6588 Cr	₹6465 Cr	₹3133 Cr	₹3037 Cr	₹3002 Cr	₹2968 Cr	₹2745 Cr	₹2445 Cr	₹4062 Cr	₹2006 Cr	₹1754 Cr	₹1475 Cr	₹2290 Cr	₹1613 Cr	₹1391 Cr
₹515 Cr	₹456 Cr	₹387 Cr	₹354 Cr	₹355 Cr	₹491 Cr	₹477 Cr	₹534 Cr	₹503 Cr	₹697 Cr	₹660 Cr	₹309 Cr	₹343 Cr	₹245 Cr	₹296 Cr	₹230 Cr	₹218 Cr	₹194 Cr	₹188 Cr	₹202 Cr	₹102 Cr	₹98 Cr	₹73 Cr	₹68 Cr
₹0	₹0	₹0	₹0	₹0	₹2 L	₹18 L	₹58 L	₹99 L	₹2 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹716 Cr	₹667 Cr	₹663 Cr	₹634 Cr	₹592 Cr	₹601 Cr	₹1452 Cr	₹559 Cr	₹406 Cr	₹299 Cr	₹228 Cr	₹363 Cr	₹343 Cr	₹316 Cr	₹316 Cr	₹363 Cr	₹333 Cr	₹326 Cr	₹311 Cr	₹298 Cr	₹297 Cr	₹297 Cr	₹301 Cr	₹314 Cr
₹436 Cr	₹384 Cr	₹343 Cr	₹305 Cr	₹262 Cr	₹215 Cr	₹696 Cr	₹129 Cr	₹83 Cr	₹46 Cr	₹24 Cr	₹240 Cr	₹243 Cr	₹227 Cr	₹217 Cr	₹254 Cr	₹240 Cr	₹236 Cr	₹223 Cr	₹208 Cr	₹207 Cr	₹197 Cr	₹188 Cr	₹183 Cr
₹280 Cr	₹283 Cr	₹320 Cr	₹329 Cr	₹329 Cr	₹386 Cr	₹757 Cr	₹430 Cr	₹323 Cr	₹253 Cr	₹204 Cr	₹123 Cr	₹100 Cr	₹89 Cr	₹99 Cr	₹109 Cr	₹93 Cr	₹90 Cr	₹87 Cr	₹90 Cr	₹90 Cr	₹100 Cr	₹112 Cr	₹132 Cr
₹33 Cr	₹14 Cr	₹14 Cr	₹20 Cr	₹31 Cr	₹13 Cr	₹120 Cr	₹1003 Cr	₹923 Cr	₹573 Cr	₹268 Cr	₹115 Cr	₹62 Cr	₹44 Cr	₹16 Cr	₹9 Cr	₹21 Cr	₹10 Cr	₹5 Cr	₹9 Cr	₹15 Cr	₹5 Cr	₹4 Cr	₹5 Cr
₹87 L	₹0	₹0	₹0	₹0	₹0	₹0	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹10 Cr	₹55 Cr	₹118 Cr	₹148 Cr	₹651 Cr	₹674 Cr	₹728 Cr	₹375 Cr	₹377 Cr	₹289 Cr	₹114 Cr
₹87 L	₹0	₹0	₹0	₹0	₹0	₹0	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹10 Cr	₹55 Cr	₹118 Cr	₹148 Cr	₹651 Cr	₹674 Cr	₹728 Cr	₹375 Cr	₹377 Cr	₹289 Cr	₹114 Cr
₹269 Cr	₹259 Cr	₹275 Cr	₹347 Cr	₹445 Cr	₹402 Cr	₹362 Cr	₹3003 Cr	₹2851 Cr	₹3882 Cr	₹3609 Cr	₹296 Cr	₹238 Cr	₹195 Cr	₹157 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹26 L	₹45 L	₹1 Cr	₹1 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹6 Cr	₹6 L	₹11 Cr	₹14 Cr	₹17 Cr	₹36 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹584 Cr	₹557 Cr	₹612 Cr	₹699 Cr	₹812 Cr	₹809 Cr	₹1248 Cr	₹4445 Cr	₹4103 Cr	₹4753 Cr	₹4087 Cr	₹546 Cr	₹413 Cr	₹355 Cr	₹363 Cr	₹236 Cr	₹263 Cr	₹751 Cr	₹767 Cr	₹827 Cr	₹480 Cr	₹481 Cr	₹406 Cr	₹251 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹1391 Cr	₹1118 Cr	₹813 Cr	₹518 Cr	₹366 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹10 Cr	₹45 Cr	₹57 Cr	₹0	₹0	₹79 Cr	₹673 Cr	₹408 Cr	₹526 Cr	₹372 Cr	₹72 Cr	₹16 L
₹458 Cr	₹482 Cr	₹525 Cr	₹460 Cr	₹535 Cr	₹547 Cr	₹483 Cr	₹486 Cr	₹500 Cr	₹426 Cr	₹526 Cr	₹376 Cr	₹347 Cr	₹285 Cr	₹333 Cr	₹286 Cr	₹257 Cr	₹233 Cr	₹211 Cr	₹247 Cr	₹222 Cr	₹230 Cr	₹205 Cr	₹202 Cr
₹273 Cr	₹293 Cr	₹222 Cr	₹192 Cr	₹205 Cr	₹216 Cr	₹100 Cr	₹120 Cr	₹147 Cr	₹171 Cr	₹127 Cr	₹100 Cr	₹96 Cr	₹116 Cr	₹85 Cr	₹47 Cr	₹54 Cr	₹58 Cr	₹38 Cr	₹60 Cr	₹67 Cr	₹76 Cr	₹67 Cr	₹82 Cr
₹1391 Cr	₹1404 Cr	₹1063 Cr	₹1156 Cr	₹2485 Cr	₹1158 Cr	₹1083 Cr	₹1171 Cr	₹1296 Cr	₹900 Cr	₹1392 Cr	₹1911 Cr	₹2042 Cr	₹2067 Cr	₹2014 Cr	₹2003 Cr	₹1734 Cr	₹957 Cr	₹155 Cr	₹36 Cr	₹48 Cr	₹72 Cr	₹77 Cr	₹141 Cr
₹57 Cr	₹87 Cr	₹150 Cr	₹155 Cr	₹89 Cr	₹46 Cr	₹48 Cr	₹109 Cr	₹74 Cr	₹105 Cr	₹57 Cr	₹115 Cr	₹77 Cr	₹87 Cr	₹78 Cr	₹54 Cr	₹30 Cr	₹46 Cr	₹29 Cr	₹28 Cr	₹20 Cr	₹22 Cr	₹14 Cr	₹5 Cr
₹37 Cr	₹26 Cr	₹25 Cr	₹12 Cr	₹28 Cr	₹56 Cr	₹60 Cr	₹1469 Cr	₹1513 Cr	₹232 Cr	₹271 Cr	₹86 Cr	₹52 Cr	₹47 Cr	₹37 Cr	₹120 Cr	₹107 Cr	₹1938 Cr	₹134 Cr	₹148 Cr	₹111 Cr	₹1037 Cr	₹771 Cr	₹710 Cr
₹3606 Cr	₹3410 Cr	₹2798 Cr	₹2494 Cr	₹3708 Cr	₹2023 Cr	₹1775 Cr	₹3356 Cr	₹3531 Cr	₹1833 Cr	₹2372 Cr	₹2587 Cr	₹2624 Cr	₹2647 Cr	₹2605 Cr	₹2510 Cr	₹2183 Cr	₹3310 Cr	₹1239 Cr	₹927 Cr	₹994 Cr	₹1809 Cr	₹1207 Cr	₹1140 Cr
₹1827 Cr	₹1505 Cr	₹1273 Cr	₹1168 Cr	₹2009 Cr	₹668 Cr	₹753 Cr	₹552 Cr	₹582 Cr	₹952 Cr	₹1589 Cr	₹1480 Cr	₹1735 Cr	₹1810 Cr	₹1745 Cr	₹1665 Cr	₹1484 Cr	₹800 Cr	₹599 Cr	₹359 Cr	₹448 Cr	₹401 Cr	₹229 Cr	₹289 Cr
₹4190 Cr	₹3967 Cr	₹3410 Cr	₹3193 Cr	₹4520 Cr	₹3012 Cr	₹3023 Cr	₹7804 Cr	₹7639 Cr	₹6588 Cr	₹6465 Cr	₹3133 Cr	₹3037 Cr	₹3002 Cr	₹2968 Cr	₹2745 Cr	₹2445 Cr	₹4062 Cr	₹2006 Cr	₹1754 Cr	₹1475 Cr	₹2290 Cr	₹1613 Cr	₹1391 Cr
₹135	₹116	₹105	₹103	₹157	₹87	₹107	₹126	₹243	₹237	₹258	₹216	₹235	₹237	₹229	₹230	₹211	₹186	₹163	₹142	₹113	₹106	₹89	₹77
₹135	₹116	₹105	₹103	₹157	₹87	₹107	₹126	₹121	₹118	₹129	₹108	₹117	₹118	₹114	₹115	₹105	₹93	₹82	₹71	₹56	₹53	₹44	₹38

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006	Dec 2005
₹1385 Cr	₹1255 Cr	₹960 Cr	₹841 Cr	₹2476 Cr	₹723 Cr	₹647 Cr	₹654 Cr	₹522 Cr	₹465 Cr	₹576 Cr	₹808 Cr	₹685 Cr	₹983 Cr	₹927 Cr	₹872 Cr	₹761 Cr	₹701 Cr	₹623 Cr	₹566 Cr	₹488 Cr
-₹65 Cr	-₹68 Cr	-₹45 Cr	-₹40 Cr	-₹1636 Cr	-₹26 Cr	₹13 Cr	-₹31 Cr	-₹12 Cr	-₹46 Cr	-₹96 Cr	-₹174 Cr	-₹156 Cr	-₹160 Cr	-₹139 Cr	-₹90 Cr	-₹70 Cr	-₹87 Cr	-₹56 Cr	-₹35 Cr	-₹19 Cr
-₹98 Cr	₹185 Cr	₹61 Cr	-₹46 Cr	₹120 Cr	₹46 Cr	₹44 Cr	-₹4 Cr	₹165 Cr	-₹27 Cr	-₹124 Cr	-₹37 Cr	₹11 Cr	₹56 Cr	-₹73 Cr	₹13 Cr	₹20 Cr	-₹33 Cr	₹12 Cr	-₹40 Cr	₹44 Cr
₹1222 Cr	₹1372 Cr	₹976 Cr	₹756 Cr	₹959 Cr	₹743 Cr	₹704 Cr	₹618 Cr	₹675 Cr	₹392 Cr	₹356 Cr	₹597 Cr	₹540 Cr	₹879 Cr	₹715 Cr	₹794 Cr	₹712 Cr	₹582 Cr	₹579 Cr	₹491 Cr	₹513 Cr
₹903 Cr	₹1290 Cr	₹582 Cr	₹484 Cr	₹811 Cr	₹578 Cr	₹491 Cr	₹409 Cr	₹473 Cr	₹234 Cr	₹139 Cr	₹338 Cr	₹281 Cr	₹314 Cr	₹335 Cr	₹479 Cr	₹512 Cr	₹330 Cr	₹319 Cr	₹259 Cr	₹349 Cr
₹397 Cr	-₹46 Cr	₹9 Cr	₹808 Cr	-₹406 Cr	₹418 Cr	-₹57 Cr	-₹153 Cr	-₹104 Cr	₹301 Cr	₹499 Cr	₹180 Cr	₹189 Cr	-₹110 Cr	₹358 Cr	₹87 Cr	₹661 Cr	₹827 Cr	₹99 Cr	-₹1 Cr	₹71 Cr
-₹737 Cr	-₹769 Cr	-₹561 Cr	-₹1543 Cr	-₹524 Cr	-₹696 Cr	-₹428 Cr	-₹358 Cr	-₹307 Cr	-₹511 Cr	-₹638 Cr	-₹497 Cr	-₹494 Cr	-₹441 Cr	-₹395 Cr	-₹297 Cr	-₹395 Cr	-₹355 Cr	-₹298 Cr	-₹269 Cr	-₹444 Cr
₹563 Cr	₹475 Cr	₹29 Cr	-₹251 Cr	-₹119 Cr	₹300 Cr	₹6 Cr	-₹102 Cr	₹62 Cr	₹24 Cr	-₹42 L	₹21 Cr	-₹24 Cr	-₹237 Cr	₹299 Cr	₹269 Cr	₹777 Cr	₹802 Cr	₹119 Cr	-₹12 Cr	-₹24 Cr
₹539 Cr	₹64 Cr	₹35 Cr	₹286 Cr	₹405 Cr	₹105 Cr	₹99 Cr	₹201 Cr	₹139 Cr	₹115 Cr	₹115 Cr	₹95 Cr	₹138 Cr	₹374 Cr	₹76 Cr	₹1734 Cr	₹957 Cr	₹155 Cr	₹36 Cr	₹48 Cr	₹72 Cr
₹1102 Cr	₹539 Cr	₹64 Cr	₹35 Cr	₹286 Cr	₹405 Cr	₹105 Cr	₹99 Cr	₹201 Cr	₹139 Cr	₹115 Cr	₹116 Cr	₹114 Cr	₹138 Cr	₹374 Cr	₹2003 Cr	₹1734 Cr	₹957 Cr	₹155 Cr	₹36 Cr	₹48 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Glaxosmithkline Pharmaceuticals Share Price

2575.10+43.70 (+1.73%)

-4.01% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Glaxosmithkline Pharmaceuticals Share Price

2575.10+43.70 (+1.73%)

-4.01% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 3

Bearish signals: 4 out of 9 oscillators

RSI

48.91Neutral

STOCH %K

88.24Sell

MACD Level(12,26)

-59.64Sell

Ultimate Oscillator

52.78Buy

Aroon Oscillator

-74.00Sell

BOP

0.53Buy

CCI

63.28Neutral

Williams %R

-11.76Sell

Momentum

38.80Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 6

Bearish signals: 3 out of 9 moving averages

EMA 9

2516.28Buy

SMA 9

2485.62Buy

EMA 21

2558.79Buy

SMA 21

2534.50Buy

EMA 50

2633.48Sell

SMA 50

2747.23Sell

EMA 200

2611.65Sell

SMA 200

2514.93Buy

WMA 20

2503.83Buy

Pivot

Classic

Resistance 5

2891.47

Resistance 4

2802.67

Resistance 3

2713.87

Resistance 2

2625.07

Resistance 1

2578.23

Pivot

2536.27

Support 1

2489.43

Support 2

2447.47

Support 3

2358.67

Support 4

2269.87

Support 5

2181.07

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

2540.40

2494.30

2344.10

2088.10

1408.15

1227.00

962.65

110.00

High

2605.90

2762.90

3120.70

3515.70

Returns

+43.70

+80.80

-157.70

-4.40

+98.20

+101.50

-107.70

+1169.95

+934.40

+1165.95

+2415.35

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Glaxosmithkline Pharmaceuticals Share Price

2575.10+43.70 (+1.73%)

-4.01% past 1 Year

Shareholding summary

Promoters

75%

FII

4.75%

DII

2.4%

MF

6.07%

Others

11.78%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
75.00%	75.00%	75.00%	75.00%	75.00%	75.00%
4.75%	4.79%	4.62%	4.63%	4.80%	4.89%
2.40%	2.94%	2.95%	2.93%	2.71%	2.54%
6.07%	4.87%	4.73%	4.77%	5.05%	5.17%
11.78%	12.40%	12.70%	12.67%	12.44%	12.40%

Bulk & block deals

Name

Ishares Core Emerging Markets Mauritius Co

Ishares India Sc Mauritius Company

Ishares Core Msci Emerging Markets Etf

Ishares Msci India Small-Cap Etf

Ishares India Sc Mauritius Company

Ishares Msci India Small-Cap Etf

Ishares Core Msci Emerging Markets Etf

Ishares Core Emerging Markets Mauritius Co

Ishares Core Msci Emerging Markets Etf

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
17 Oct 2022	Sell	11.11 Cr	₹1,378.65	80.61 K	Block	0.047587	BSE
17 Oct 2022	Sell	1.63 Cr	₹1,378.65	11.84 K	Block	0.00699	BSE
17 Oct 2022	Purchase	11.11 Cr	₹1,378.65	80.61 K	Block	0.047587	BSE
17 Oct 2022	Purchase	1.63 Cr	₹1,378.65	11.84 K	Block	0.00699	BSE
11 Oct 2022	Sell	1.59 Cr	₹1,393.45	11.42 K	Block	0.006739	BSE
11 Oct 2022	Purchase	1.59 Cr	₹1,393.45	11.42 K	Block	0.006739	BSE
11 Oct 2022	Purchase	10.83 Cr	₹1,393.45	77.73 K	Block	0.045886	BSE
11 Oct 2022	Sell	10.83 Cr	₹1,393.45	77.73 K	Block	0.045886	BSE
03 Oct 2022	Sell	11.03 Cr	₹1,424.40	77.44 K	Block	0.045712	NSE
03 Oct 2022	Purchase	11.03 Cr	₹1,424.40	77.44 K	Block	0.045712	NSE

Insider trading & SAST

Client name

Life Insurance Corporation Of India

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
21 Sep 2022	Other	Disposal	2.04	4.35	0	—	34.64 L	11 Sep 2018 - 13 Sep 2022	Market	73,80,777	SAST	29(2)	—

Glaxosmithkline Pharmaceuticals Share Price

2575.10+43.70 (+1.73%)

-4.01% past 1 Year

GlaxoSmithKline (GSK) Pharmaceuticals, a subsidiary of UK-based GSK plc, is a leading global biopharma company bringing together science, technology and talent to deliver impact and get ahead of disease together

Corporate Actions

Date

Type

Details

2026-05-29

Dividend

57.0

2025-05-30

Dividend

42.0

2024-11-07

Dividend

12.0

2024-05-31

Dividend

32.0

2023-06-30

Dividend

32.0

2022-07-07

Dividend

90.0

2021-07-19

Dividend

30.0

2020-07-17

Dividend

40.0

2019-07-11

Dividend

20.0

2018-09-11

Bonus

1:1

2018-07-13

Dividend

35.0

2017-07-14

Dividend

30.0

2016-07-15

Dividend

50.0

2015-07-23

Dividend

112.0

2014-04-03

Dividend

50.0

2013-04-04

Dividend

50.0

2012-03-29

Dividend

45.0

2011-03-14

Dividend

40.0

Company details

Registered office

252, Gsk House Dr. Annie Besant Road Worli Mumbai Maharashtra PIN: 400030 Tel No: 022-24959595 Fax No: 022-24959494 Email: [email protected] / [email protected] Internet: www.gsk-india.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

R S Karnad, Chairperson

Bhushan Akshikar, Managing Director

Manu Anand, Non Executive Independent Director

Ronojit Biswas, Whole Time Director & Chief Financial Officer

S Maheshwari, Non Executive Independent Director

P R Somasundaram, Non Executive Independent Director

Anup Wadhawan, Non Executive Independent Director

S Williams, Non Executive Director

Ajay Nadkarni, Company Secretary & Compliance Officer, Vice President – Administration, Real Estate

Karine JF Natland, Non-Execuive Director

Details